Download PDF
Neuropediatrics 2002; 33(6): 281-287
DOI: 10.1055/s-2002-37089
Review Article

Georg Thieme Verlag Stuttgart · New York

Adult Stroke and Perinatal Brain Damage: Like Grandparent, Like Grandchild?

A. Leviton 1 , O. Dammann 1 , 2 , T. M. O'Shea 3 , N. Paneth 4
  • 1Neuroepidemiology Unit, Children's Hospital, Boston, MA, USA
  • 2Department of Obstetrics, Prenatal Medicine and General Gynecology, Department of Pediatrics, Pediatric Pulmonology, and Neonatology, Perinatal Infectiology Unit, Hannover Medical School, Hannover, Germany
  • 3Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC, USA
  • 4Department of Epidemiology, College of Human Medicine, Michigan State University, East Lansing, MI, USA
Further Information

Publication History

Received: 8 August 2002

Accepted after Revision: 14 November 2002

Publication Date:
06 February 2003 (online)

    Permissions and Reprints

Abstract

Biomarkers of inflammation are found in the circulation of adults who have had a stroke. Although these biomarkers may, in part, be indicators of damage, some appear to contribute to damage. Similar biomarkers are found in newborns with cerebral white matter damage or at risk of cerebral palsy. Can we learn about the pathogenesis of neonatal white matter damage from what has been learned about the inflammatory correlates of adult stroke? We discuss relevant findings about systemic inflammatory markers in adult stroke and relate this information to our current understanding of cerebral white matter damage in newborns, especially those born at an extremely low gestational age. We also describe desirable characteristics of future studies of perinatal brain damage that involve measurements of systemic biomarkers.

Key words

Infant - Newborn - Brain - Inflammation - Stroke

References

  • 1 Abraha H D, Butterworth R J, Bath P M, Wassif W S, Garthwaite J, Sherwood R A. Serum S-100 protein, relationship to clinical outcome in acute stroke.  Ann Clin Biochem. 1997;  34 366-370
    PubMedGoogle Scholar
  • 2 Alexander R W. Inflammation and coronary artery disease.  N Engl J Med. 1994;  331 468-469
    CrossrefPubMedGoogle Scholar
  • 3 Anwaar I, Gottsater A, Lindgarde F, Mattiasson I. Increasing plasma neopterin and persistent plasma endothelin during follow-up after acute cerebral ischemia.  Angiology. 1999;  50 1-8
    PubMedGoogle Scholar
  • 4 Barone F C, Feuerstein G Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics.  J Cereb Blood Flow Metab. 1999;  19 819-834
    PubMedGoogle Scholar
  • 5 Barone F C, Ohlstein E H, Hunter A J, Campbell C A, Hadingham S H, Parsons A A. et al . Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.  J Cardiovasc Pharmacol. 2000;  36 S357-S361
    CrossrefPubMedGoogle Scholar
  • 6 Beamer N B, Coull B M, Clark W M, Hazel J S, Silberger J R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke.  Ann Neurol. 1995;  37 800-805
    CrossrefPubMedGoogle Scholar
  • 7 Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P. A longitudinal prospective study of soluble adhesion molecules in acute stroke.  Stroke. 1998;  29 2129-2135
    PubMedGoogle Scholar
  • 8 Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.  Stroke. 1997;  28 1961-1965
    PubMedGoogle Scholar
  • 9 Carlson N G, Wieggel W A, Chen J, Bacchi A, Rogers S W, Gahring L C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.  J Immunol. 1999;  163 3963-3968
    PubMedGoogle Scholar
  • 10 Chen J, Simon R. Ischemic tolerance in the brain.  Neurology. 1997;  48 306-311
    PubMedGoogle Scholar
  • 11 Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation.  Inflamm Res. 1997;  46 382-391
    CrossrefPubMedGoogle Scholar
  • 12 Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage?.  Trends Neurosci. 2001;  24 320-324
    CrossrefPubMedGoogle Scholar
  • 13 Dammann O, Phillips T M, Allred E N, O'Shea T M, Paneth N, Van Marter L J. et al . Mediators of fetal inflammation in extremely low gestational age newborns.  Cytokine. 2001;  13 234-239
    CrossrefPubMedGoogle Scholar
  • 14 Davies M J, Gordon J L, Gearing A J, Pigott R, Woolf N, Katz D. et al . The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis.  J Pathol. 1993;  171 223-229
    CrossrefPubMedGoogle Scholar
  • 15 del Zoppo G, Ginis I, Hallenbeck J M, Iadecola C, Wang X, Feuerstein G Z. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.  Brain Pathol. 2000;  10 95-112
    PubMedGoogle Scholar
  • 16 Diez-Ruiz A, Tilz G P, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.  Eur J Haematol. 1995;  54 1-8
    PubMedGoogle Scholar
  • 17 Duggan P J, Maalouf E F, Watts T L, Sullivan M H, Counsell S J, Allsop J. et al . Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions.  Lancet. 2001;  358 1699-1700
    CrossrefPubMedGoogle Scholar
  • 18 Elkind M S, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H. et al . Tumor necrosis factor receptor levels are associated with carotid atherosclerosis.  Stroke. 2002;  33 31-38
    CrossrefPubMedGoogle Scholar
  • 19 Elneihoum A M, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases.  Stroke. 1996;  27 1734-1738
    PubMedGoogle Scholar
  • 20 Els T, Bruckmann J, Rohn G, Daffertshofer M, Monting J S, Ernestus R I. et al . Spermidine: A predictor for neurological outcome and infarct size in focal cerebral ischemia?.  Stroke. 2001;  32 43-46
    PubMedGoogle Scholar
  • 21 Estrada V, Tellez M J, Moya J, Fernandez-Durango R, Egido J, Fernandez Cruz A F. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke.  Am J Hypertens. 1994;  7 1085-1089
    PubMedGoogle Scholar
  • 22 Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease.  Stroke. 1999;  30 1647-1650
    PubMedGoogle Scholar
  • 23 Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke.  Stroke. 1995;  26 1361-1364
    CrossrefPubMedGoogle Scholar
  • 24 Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M. et al . Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.  J Neurol Sci. 1994;  122 135-139
    CrossrefPubMedGoogle Scholar
  • 25 Fassbender K, Schmidt R, Schreiner A, Fatar M, Muhlhauser F, Daffertshofer M. et al . Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.  J Neurol Sci. 1997;  148 101-105
    CrossrefPubMedGoogle Scholar
  • 26 Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B. et al . Increased cytokine release from peripheral blood cells after acute stroke.  J Cereb Blood Flow Metab. 1999;  19 1004-1009
    PubMedGoogle Scholar
  • 27 Fijnheer R, Frijns C J, Korteweg J, Rommes H, Peters J H, Sixma J J. et al . The origin of P-selectin as a circulating plasma protein.  Thromb Haemost. 1997;  77 1081-1085
    PubMedGoogle Scholar
  • 28 Frenette P S, Wagner D D. Adhesion molecules - Part 1.  N Engl J Med. 1996;  334 1526-1529
    CrossrefPubMedGoogle Scholar
  • 29 Frijns C J, Kappelle L J, van Gijn J, Nieuwenhuis H K, Sixma J J, Fijnheer R. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis.  Stroke. 1997;  28 2214-2218
    PubMedGoogle Scholar
  • 30 Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice.  J Cereb Blood Flow Metab. 2000;  20 53-65
    PubMedGoogle Scholar
  • 31 Grether J K, Nelson K B, Dambrosia J M, Phillips T M. Interferons and cerebral palsy.  J Pediatr. 1999;  134 324-332
    PubMedGoogle Scholar
  • 32 Haapaniemi E, Tatlisumak T, Hamel K, Soinne L, Lanni C, Opgenorth T J. et al . Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke.  Stroke. 2000;  31 720-725
    PubMedGoogle Scholar
  • 33 Hamann G F, Isenberg E, Strittmatter M, Moili R, Schimrigk K. Bigendothelin in acute ischemic stroke.  J Stroke Cerebrovasc Dis. 1993;  3 256-260
    PubMedGoogle Scholar
  • 34 Hamann G F, Isenberg E, Strittmatter M, Stoll M, Keshevar T, Moili R. et al . Big endothelin in spontaneous intracerebral hemorrhage.  Eur Neurol. 1994;  34 99-102
    PubMedGoogle Scholar
  • 35 Herrmann M, Vos P, Wunderlich M T, de Bruijn C H, Lamers K J. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100 B and glial fibrillary acidic protein.  Stroke. 2000;  31 2670-2677
    CrossrefPubMedGoogle Scholar
  • 36 Idriss H T, Naismith J H. TNF alpha and the TNF receptor superfamily: structure-function relationship(s).  Microsc Res Tech. 2000;  50 184-195
    CrossrefPubMedGoogle Scholar
  • 37 Kaneko M, Sasahara M, Takayama S, Handa J, Hazama F. Expression of platelet-derived growth factor after transient forebrain ischemia in the gerbil hippocampus.  Acta Neuropathol (Berl). 1998;  95 471-478
    CrossrefPubMedGoogle Scholar
  • 38 Kim J S, Yoon S S, Kim Y H, Ryu J S. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke.  Stroke. 1996;  27 1553-1557
    PubMedGoogle Scholar
  • 39 Kim J S, Chopp M, Chen H, Levine S R, Carey J L, Welch K M. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks.  J Neurol Sci. 1995;  128 45-50
    CrossrefPubMedGoogle Scholar
  • 40 Kostulas N, Pelidou S H, Kivisakk P, Kostulas V, Link H. Increased IL-1 beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study.  Stroke. 1999;  30 2174-2179
    PubMedGoogle Scholar
  • 41 Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, Link H. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA.  Stroke. 1998;  29 462-466
    PubMedGoogle Scholar
  • 42 Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S. Endothelial markers and adhesion molecules in acute ischemic stroke - sequential change and differences in stroke subtype.  Atherosclerosis. 2002;  161 161-168
    CrossrefPubMedGoogle Scholar
  • 43 Kuban K C. White-matter disease of prematurity, periventricular leukomalacia, and ischemic lesions.  Dev Med Child Neurol. 1998;  40 571-573
    CrossrefPubMedGoogle Scholar
  • 44 Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke.  Stroke. 1997;  28 1951-1955
    PubMedGoogle Scholar
  • 45 Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects.  Acta Paediatr. 2002;  91 9-13
    PubMedGoogle Scholar
  • 46 Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions.  Biochim Biophys Acta. 2000;  1497 1-10
    PubMedGoogle Scholar
  • 47 Minagawa K, Tsuji Y, Ueda H, Koyama K, Tanizawa K, Okamura H. et al . Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy.  Cytokine. 2002;  17 164-170
    CrossrefPubMedGoogle Scholar
  • 48 Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.  Stroke. 1997;  28 1956-1960
    PubMedGoogle Scholar
  • 49 Munoz A, Gange S J. Methodological issues for biomarkers and intermediate outcomes in cohort studies.  Epidemiol Rev. 1998;  20 29-42
    PubMedGoogle Scholar
  • 50 Nelson K B, Dambrosia J M, Grether J K, Phillips T M. Neonatal cytokines and coagulation factors in children with cerebral palsy.  Ann Neurol. 1998;  44 665-675
    Google Scholar
  • 51 Paul R, Zhang Z G, Eliceiri B P, Jiang Q, Boccia A D, Zhang R L. et al . Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke.  Nat Med. 2001;  7 222-227
    PubMedGoogle Scholar
  • 52 Pelidou S H, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases.  Eur J Neurol. 1999;  6 437-442
    CrossrefPubMedGoogle Scholar
  • 53 Shyu K G, Chang H, Lin C C. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke.  J Neurol. 1997;  244 90-93
    PubMedGoogle Scholar
  • 54 Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.  Stroke. 2000;  31 1863-1870
    PubMedGoogle Scholar
  • 55 Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S. et al . Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.  Stroke. 1995;  26 1393-1398
    PubMedGoogle Scholar
  • 56 Temesgen Z, Girard S E. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.  Expert Opin Pharmacother. 2001;  2 765-772
    CrossrefPubMedGoogle Scholar
  • 57 Tilg H, Trehu E, Atkins M B, Dinarello C A, Mier J W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.  Blood. 1994;  83 113-118
    PubMedGoogle Scholar
  • 58 Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines.  Crit Care Med. 2000;  28 1854-1860
    PubMedGoogle Scholar
  • 59 Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke.  Stroke. 2000;  31 2325-2329
    PubMedGoogle Scholar
  • 60 Wu G, Li F, Li P, Ruan C. Detection of plasma alpha-granule membrane protein GMP-140 using radiolabeled monoclonal antibodies in thrombotic diseases.  Haemostasis. 1993;  23 121-128
    PubMedGoogle Scholar
  • 61 Wunderlich M T, Ebert A D, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.  Stroke. 1999;  30 1190-1195
    PubMedGoogle Scholar
  • 62 Yoon B H, Romero R, Yang S H, Jun J K, Kim I O, Choi J H. et al . Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia.  Am J Obstet Gynecol. 1996;  174 1433-1440
    CrossrefPubMedGoogle Scholar
  • 63 Zhao B, Schwartz J P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives.  J Neurosci Res. 1998;  52 7-16
    CrossrefPubMedGoogle Scholar
  • 64 Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke.  Stroke. 1992;  23 1014-1016
    PubMedGoogle Scholar

M. D. Olaf Dammann

Department of Obstetrics, Prenatal Medicine and General Gynecology · Department of Pediatrics, Pediatric Pulmonology, and Neonatology, Perinatal Infectiology Unit, OE 6415 · Hannover Medical School

Carl-Neuberg Str. 1

30623 Hannover

Germany

Email: dammann.olaf@mh-hannover.de

      >